Re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285-93: Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients.

Wambier, Carlos G; Nau, Gerard J

Wambier, Carlos G; Nau, Gerard J.

Wambier CG; The Warren Alpert Medical School, Brown University, Providence, RI, USA. Electronic address: carlos_wambier@brown.edu.
Nau GJ; The Warren Alpert Medical School, Brown University, Providence, RI, USA.

Eur Urol ; 81(6): e141-e142, 2022 06.

Article in English | MEDLINE | ID: covidwho-1699904

Subject(s)

COVID-19; Androgen Antagonists/therapeutic use; Benzamides; Humans; Nitriles; Phenylthiohydantoin

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Eur Urol Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google